Charles River partners with Magellan Stem Cells on cGMP NGS viral safety testing for osteoarthritis therapy program
Bitget2026/10/13 12:02- Charles River Laboratories entered a collaboration with Australia’s Magellan Stem Cells to support development of Magellan’s stem cell therapies.
- Charles River will provide cGMP viral safety testing using next-generation sequencing to support regulatory-ready quality control for cell therapies.
- Magellan is preparing a pivotal Phase III program for Zelestrocel, an allogeneic off-the-shelf osteoarthritis stem cell therapy candidate.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Strive's bitcoin holdings increased to 35,595, and TD Cowen raised its target price to $56.
New York Federal Reserve Survey: Service Sector Price Increases Hit Fastest Pace Since 2022, Business Activity Index Drops to Lowest Since March
A survey released by the New York Fed on Friday shows that in October, sales prices for service sector firms increased at the fastest pace since 2022, with input costs remaining robust and supply conditions continuing to deteriorate. Businesses’ pessimism about the commercial outlook has significantly intensified, with the overall business activity index falling by 12 points from the previous month to minus 20.7, marking the weakest reading since March.
Raoul Pal Holds Bitcoin, Solana and Ethereum, but Calls One Wildly Undervalued
Ethos Technologies President Wang Lingke Reports Sale of $4.54 Million in Common Shares
Crypto prices
More
